ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Early Readmission After Renal Transplant As A Valuable Quality Measure

S. Kim1, A. Osband1, B. Merhi2, G. Bayliss2, R. Gohh2, P. Morrissey1

1Surgery, Rhode Island Hospital, Providence, RI, 2Nephrology, Rhode Island Hospital, Providence, RI

Meeting: 2019 American Transplant Congress

Abstract number: D31

Keywords: Adverse effects, Kidney transplantation, Prediction models

Session Information

Session Name: Poster Session D: Quality Assurance Process Improvement & Regulatory Issues

Session Type: Poster Session

Date: Tuesday, June 4, 2019

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall C & D

*Purpose: Patient and graft survival have been criticized as imprecise measures of transplant program quality. Thirty-day (30d) readmission rates, available nationally and attainable locally, may better reflect the efficacy of multi-disciplinary transplant care and are therefore an important benchmark for quality improvement purposes. Nationally, renal transplant recipients incur a 31% readmission rate in the first month. The impact of early (30d) readmission rates at single centers provides a useful benchmark and may identify modifiable program-specific issues to reduce readmission and improve patient outcomes.

*Methods: We reviewed 269 consecutive kidney transplant recipients over a five-year period (2012-2016). Readmissions were identified from RIH transplant clinic records and individual patient records were reviewed to abstract data with >1 year follow-up on all patients. Prior to discharge all patients met with a transplant coordinator (RN), pharmacist, and nutritionist for formal teaching sessions. All patients were seen by a visiting nurse (VNA) at home, typically for two weeks after discharge. All statistical analyses were conducted using SAS Software 9.4 (SAS Inc., Cary, NC). Alpha was established at the .05 level and all interval estimates were calculated for 95% confidence.

*Results: The patients were male (59%), white (72%), diabetic (27%) and the majority (63.9%) had only public insurance. The median age at transplant was 55, days on dialysis 1039, and cold ischemia time 15 hours (deceased donors). Deceased donors (n=187, 78 DCD, 109 DBD) predominated and 1/3 of these developed DGF. Median length of stay was 6 days (IQR 5-7) days. Twenty-one percent were readmitted within 30d; 75% for surgical, metabolic, infectious complications, or acute kidney injury. Deceased kidney donation, ATG induction, diabetes, public insurance, and weekend discharge were all identified as risk factors for readmission (Table 1). Readmission was not correlated with risk of death (5.4% at 44 months: HR 2.2 (95% CI [0.7, 6.6]; p=0.1473) or graft loss.

*Conclusions: Early readmission after renal transplantation was common. The reasons were multiple and not associated with demographic factors beyond insurance type, which may reflect socioeconomic status. Deceased donation and poor early allograft function were associated with increased risk for readmission. A multi-disciplinary approach to discharge planning and home VNA care may reduce readmissions, but most complications and adverse events were unpredictable and required hospital-level of care.

Predictors of 30d Readmission
Item OR 95% CI P value
DGF 2.4 1.3 – 4.5 0.006
IDDM 2.1 1.1 – 3.9 0.02
Public Insurance 2.2 1.1 – 4.4 0.03
ATG use 2.3 1.2 – 4.3 0.01
PRA > 20% 1.7 0.9 – 3.2 0.09
DCD vs, live donor 3.4 1.4 – 8.3 0.007
DBD vs. live donor 3.0 1.3 – 7.1 0.01
  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kim S, Osband A, Merhi B, Bayliss G, Gohh R, Morrissey P. Early Readmission After Renal Transplant As A Valuable Quality Measure [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/early-readmission-after-renal-transplant-as-a-valuable-quality-measure/. Accessed May 8, 2025.

« Back to 2019 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences